This protocol is judged by an institutional overview board, an impartial group that critiques any scientific trials involving human beings. If a research involves a Routine I drug, once the board approves the protocol as moral, the scientists have to submit an application for an investigational new drug (IND) selection within the FDA.“It’s cruc